Amyris Continues Strong Momentum and Execution with 77% Revenue Growth and Exceeds Gross Margin Target
May 14, 2018 16:00 ET
|
Amyris, Inc.
Q1 2018 GAAP revenue of $23.0 million, compared with GAAP revenue of $13.0 million for Q1 2017, representing 77% growth over first quarter of 2017.Q1 2018 Non-GAAP gross margin of $19.0 million, or...
Amyris to Participate in Upcoming Investor Conferences
May 10, 2018 08:30 ET
|
Amyris, Inc.
EMERYVILLE, Calif., May 10, 2018 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that it plans to participate in the following upcoming investor...
Amyris Presents Its No Compromise™ Product Portfolio at Techonomy New York
May 09, 2018 08:30 ET
|
Amyris, Inc.
EMERYVILLE, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, will be presenting its portfolio of commercialized products at Techonomy New York...
Amyris to Announce First Quarter 2018 Financial Results on Monday, May 14, 2018
May 08, 2018 13:05 ET
|
Amyris, Inc.
EMERYVILLE, Calif., May 08, 2018 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS) will report financial results for the first quarter ended March 31, 2018 after market close on Monday, May 14, 2018. ...
Amyris Collaborates with Firmenich to Develop Disruptive Bio-Based Fragrance Ingredient
May 03, 2018 08:30 ET
|
Amyris, Inc.
EMERYVILLE, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that it successfully collaborated with its fragrance partner,...
Amyris to Present at H.C. Wainwright Global Life Sciences Investment Conference on April 9, 2018
April 03, 2018 08:30 ET
|
Amyris, Inc.
EMERYVILLE, Calif., April 03, 2018 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that management will be presenting at the H.C. Wainwright Global...
Amyris Reports Another Strong Quarter with Solid Operating Performance and 2017 Revenue of $143.4 Million up 113% over 2016
March 15, 2018 16:00 ET
|
Amyris, Inc.
Q4 2017 GAAP revenue of $80.6 million, compared with GAAP revenue of $22.2 million for Q4 2016 Q4 2017 operating income of $33.0 million compared with Q4 2016 operating loss of $34.5 millionQ4 2017...
Amyris to Announce Fourth Quarter and Fiscal Year 2017 Financial Results on Thursday, March 15, 2018
February 26, 2018 08:30 ET
|
Amyris, Inc.
EMERYVILLE, Calif., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS) will report financial results for the fourth quarter and fiscal year ended December 31, 2017 after market close on...
Amyris Aprinnova Joint Venture Launches Pharmaceutical Grade Neossance Squalane USP – Opens New Market Among FDA Regulated Products
February 08, 2018 08:30 ET
|
Amyris, Inc.
EMERYVILLE, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that Aprinnova, its joint venture with NIKKOL GROUP (“NIKKOL”),...
Amyris Biossance Starts 2018 with Over 300% Retail Sales Growth – Now Available Across SEPHORA Canada Stores
February 01, 2018 08:30 ET
|
Amyris, Inc.
EMERYVILLE, Calif., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Biossance™, the consumer beauty brand from Amyris, Inc. (NASDAQ:AMRS), today announced its innovative line of clean beauty products will be...